Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Best Practice & Research. Clinical Gastroenterology|April 5, 2003
Transition of care between paediatric and adult gastroenterology. Chronic viral hepatitisPatrick Marcellin, Nathalie BoyerHepatology (Baltimore, Md.)|October 31, 2002
Fibrosis and disease progression in hepatitis CPatrick Marcellin, Tarik Asselah, Nathalie BoyerLa Revue Du Praticien|May 26, 2005
[Treatment of chronic hepatitis B]Patrick Marcellin, Tarik Asselah, Nathalie BoyerThe Lancet. Gastroenterology & Hepatology|October 15, 2019
Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cureTarik Asselah, Dimitri Loureiro, Nathalie Boyer, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectivesTarik Asselah, Nathalie Boyer, David Saadoun, et al.Clinics in Liver Disease|November 6, 2007
Interferon therapy for chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Journal of Hepatology|April 26, 2020
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug developmentIssam Tout, Dimitri Loureiro, Abdellah Mansouri, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
The current status of antiviral therapy of chronic hepatitis BTarik Asselah, Marie-Pierre Ripault, Corinne Castelnau, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Future treatments for hepatitis delta virus infectionTarik Asselah, Dimitri Loureiro, Issam Tout, et al.Clinical Pharmacokinetics|April 15, 2005
Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis CMichel Tod, Muriel Farcy-Afif, Jeanick Stocco, et al.Pageof 5